{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:04:06Z","timestamp":1788433446582,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00280-019-03974-4","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T11:45:40Z","timestamp":1571831140000},"page":"1359-1363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of the DPYD variant (Y186C) in Brazilian individuals of African ancestry"],"prefix":"10.1007","volume":"84","author":[{"given":"Geraldo Fel\u00edcio","family":"Cunha-Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9053-7201","authenticated-orcid":false,"given":"Luciana","family":"Bastos-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro G.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida","family":"Bicalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Alexandre V.","family":"Magno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Gonzaga","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"3974_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG (2003) 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330\u2013338","journal-title":"Nat Rev Cancer"},{"key":"3974_CR2","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1200\/JCO.1998.16.11.3537","volume":"16","author":"Meta-Analysis Group In Cancer, L\u00e9vy E, Piedbois P, Buyse M, Pignon JP, Rougier P, Ryan L, Hansen R, Zee B, Weinerman B, Pater J, Leichman C, Macdonald J, Benedetti J, Lokich J, Fryer J, Brufman G, Isacson R, Laplanche A, Quinaux E, Thirion P","year":"1998","unstructured":"Meta-Analysis Group In Cancer, L\u00e9vy E, Piedbois P, Buyse M, Pignon JP, Rougier P, Ryan L, Hansen R, Zee B, Weinerman B, Pater J, Leichman C, Macdonald J, Benedetti J, Lokich J, Fryer J, Brufman G, Isacson R, Laplanche A, Quinaux E, Thirion P (1998) Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol 16:3537\u20133541","journal-title":"J Clin Oncol"},{"key":"3974_CR3","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1200\/JCO.2006.10.4182","volume":"26","author":"Schwab M, Zanger UM, Marx C, Schaeffeler E, Klein K, Dippon J, Kerb R, Blievernicht J, Fischer J, Hofmann U, Bokemeyer C, Eichelbaum M; German 5-FU Toxicity Study Group","year":"2008","unstructured":"Schwab M, Zanger UM, Marx C, Schaeffeler E, Klein K, Dippon J, Kerb R, Blievernicht J, Fischer J, Hofmann U, Bokemeyer C, Eichelbaum M; German 5-FU Toxicity Study Group (2008) Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group. J Clin Oncol 26:2131\u20132138","journal-title":"J Clin Oncol"},{"key":"3974_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/tpj.2013.25","volume":"13","author":"MC van Staveren","year":"2013","unstructured":"van Staveren MC, Guchelaar HJ, van Kuilenburg AB, Gelderblom H, Maring JG (2013) Evaluation of predictive tests for screening for dihydropyrimidine dehydrogenase deficiency. Pharmcogenom J 13:389\u2013395","journal-title":"Pharmcogenom J"},{"key":"3974_CR5","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/S1470-2045(15)00286-7","volume":"16","author":"D Meulendijks","year":"2015","unstructured":"Meulendijks D, Henricks LM, Sonke GS, Deenen MJ, Froehlich TK, Amstutz U, Largiad\u00e8r CR, Jennings BA, Marinaki AM, Sanderson JD, Kleibl Z, Kleiblova P, Schwab M, Zanger UM, Palles C, Tomlinson I, Gross E, van Kuilenburg AB, Punt CJ, Koopman M, Beijnen JH, Cats A, Schellens JH (2015) Clinical relevance of DPYD variants c.1679T\u2009>\u2009G, c.1236G\u2009>\u2009A\/HapB3, and c.1601G\u2009>\u2009A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data. Lancet Oncol 16:1639\u20131650","journal-title":"Lancet Oncol"},{"key":"3974_CR6","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1158\/0008-5472.CAN-12-3858","volume":"73","author":"SM Offer","year":"2013","unstructured":"Offer SM, Wegner NJ, Fossum C, Wang K, Diasio RB (2013) Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity. Cancer Res 73:1958\u20131968","journal-title":"Cancer Res"},{"key":"3974_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/cpt.685","volume":"102","author":"Q Nie","year":"2017","unstructured":"Nie Q, Shrestha S, Tapper EE, Trogstad-Isaacson CS, Bouchonville KJ, Lee AM, Wu R, Jerde CR, Wang Z, Kubica PA, Offer SM, Diasio RB (2017) Quantitative contribution of rs75017182 to dihydropyrimidine dehydrogenase mRNA splicing and enzyme activity. Clin Pharmacol Ther 102:662\u2013670","journal-title":"Clin Pharmacol Ther"},{"key":"3974_CR8","unstructured":"The International Genome Sample Resource (IGSR). Providing ongoing support for the 1000 Genomes Project data. Genome Browsers: 1000 Genomes data in Ensemble. 2018. Available at: < http:\/\/www.internationalgenome.org\/1000-genomes-browsers >"},{"key":"3974_CR9","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/1078-0432.CCR-06-0747","volume":"12","author":"LK Mattison","year":"2006","unstructured":"Mattison LK, Fourie J, Desmond RA, Modak A, Saif MW, Diasio RB (2006) Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians. Clin Cancer Res 12:5491\u20135495","journal-title":"Clin Cancer Res"},{"key":"3974_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/FPC.0b013e3282f01788","volume":"17","author":"HR Thomas","year":"2007","unstructured":"Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB (2007) Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism. Pharmacogenet Genom 17:973\u2013987","journal-title":"Pharmacogenet Genom"},{"key":"3974_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/FPC.0b013e3282f2f134","volume":"18","author":"HR Thomas","year":"2008","unstructured":"Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB (2008) Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism. Pharmacogenet Genom 18:25\u201335","journal-title":"Pharmacogenet Genom"},{"key":"3974_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/clpt.2013.69","volume":"94","author":"SM Offer","year":"2013","unstructured":"Offer SM, Lee AM, Mattison LK, Fossum C, Wegner NJ, Diasio RB (2013) A DPYD variant (Y186C) in individuals of African ancestry is associated with reduced DPD enzyme activity. Clin Pharmacol Ther 94:158\u2013166","journal-title":"Clin Pharmacol Ther"},{"issue":"24 Pt 1","key":"3974_CR13","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1158\/1078-0432.CCR-05-1520","volume":"11","author":"HH Ezzeldin","year":"2005","unstructured":"Ezzeldin HH, Lee AM, Mattison LK, Diasio RB (2005) Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients. Clin Cancer Res 11(24 Pt 1):8699\u20138705","journal-title":"Clin Cancer Res"},{"key":"3974_CR14","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1158\/0008-5472.CAN-13-2482","volume":"74","author":"SM Offer","year":"2014","unstructured":"Offer SM, Fossum CC, Wegner NJ, Stuflesser AJ, Butterfield GL, Diasio RB (2014) Comparative functional analysis of DPYD variants of potential clinical relevance to dihydropyrimidine dehydrogenase activity. Cancer Res 74:2545\u20132554","journal-title":"Cancer Res"},{"issue":"2","key":"3974_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/clpt.2013.207","volume":"95","author":"S M Offer","year":"2013","unstructured":"Offer SM, Diasio RB (2014) Response to \u201cA case of 5-FU-related severe toxicity associated with the p.Y186C DPYD variant\u201d. Clin Pharmacol Ther 95:137","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"3974_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mayocp.2013.09.008","volume":"89","author":"MW Saif","year":"2014","unstructured":"Saif MW, Lee AM, Offer SM, McConnell K, Relias V, Diasio RB (2014) A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxicity potential for an individualized medicine approach. Mayo Clin Proc 89:131\u2013136","journal-title":"Mayo Clin Proc"},{"key":"3974_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/clpt.2013.183","volume":"95","author":"A Zaanan","year":"2014","unstructured":"Zaanan A, Dumont LM, Loriot MA, Taieb J, Narjoz C (2014) A case of 5-FU-related severe toxicity associated with the p.Y186C DPYD variant. Clin Pharmacol Ther 95:136","journal-title":"Clin Pharmacol Ther"},{"key":"3974_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/cpt.531","volume":"101","author":"T Elraiyah","year":"2017","unstructured":"Elraiyah T, Jerde CR, Shrestha S, Wu R, Nie Q, Giama NH, Sarangi V, Roberts LR, Offer SM, Diasio RB (2017) Novel deleterious dihydropyrimidine dehydrogenase variants may contribute to 5-fluorouracil sensitivity in an East African population. Clin Pharmacol Ther 101:382\u2013390","journal-title":"Clin Pharmacol Ther"},{"issue":"Pt 5","key":"3974_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1469-1809.2006.00287.x","volume":"70","author":"L Bastos-Rodrigues","year":"2006","unstructured":"Bastos-Rodrigues L, Pimenta J, Pena S (2006) The genetic structure of human populations studied through short insertion\u2013deletion polymorphisms. Ann Hum Genet 70(Pt 5):658\u2013665","journal-title":"Ann Hum Genet"},{"key":"3974_CR20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/genetics\/155.2.945","volume":"155","author":"JK Pritchard","year":"2010","unstructured":"Pritchard JK, Stephens M, Donnelly P (2010) Inference of population structure using multilocus genotype data. Genetics 155:945\u2013959","journal-title":"Genetics"},{"key":"3974_CR21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1126\/science.1172257","volume":"324","author":"SA Tishkoff","year":"2009","unstructured":"Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo JM, Doumbo O, Ibrahim M, Juma AT, Kotze MJ, Lema G, Moore JH, Mortensen H, Nyambo TB, Omar SA, Powell K, Pretorius GS, Smith MW, Thera MA, Wambebe C, Weber JL, Williams SM (2009) The genetic structure and history of Africans and African Americans. Science 324:1035\u20131044","journal-title":"Science"},{"key":"3974_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1126\/science.aal1988","volume":"356","author":"E Patin","year":"2017","unstructured":"Patin E, Lopez M, Grollemund R, Verdu P, Harmant C, Quach H, Laval G, Perry GH, Barreiro LB, Froment A, Heyer E, Massougbodji A, Fortes-Lima C, Migot-Nabias F, Bellis G, Dugoujon JM, Pereira JB, Fernandes V, Pereira L, Van der Veen L, Mouguiama-Daouda P, Bustamante CD, Hombert JM, Quintana-Murci L (2017) Dispersals and genetic adaptation of Bantu-speaking populations in Africa and North America. Science 356:543\u2013546","journal-title":"Science"},{"key":"3974_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00280-013-2309-4","volume":"72","author":"GF Cunha-Junior","year":"2013","unstructured":"Cunha-Junior GF, De Marco L, Bastos-Rodrigues L, Bolina MB, Martins FL, Pianetti GA, Cesar IC, Coelho LG (2013) (13)C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients. Cancer Chemother Pharmacol 72:1273\u20131282","journal-title":"Cancer Chemother Pharmacol"},{"key":"3974_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.clinbiochem.2016.07.004","volume":"49","author":"AF Galarza","year":"2016","unstructured":"Galarza AF, Linden R, Antunes MV, Hahn RZ, Raymundo S, da Silva AC, Staggemeier R, Spilki FR, Schwartsmann G (2016) Endogenous plasma and salivary uracil to dihydrouracil ratios and DPYD genotyping as predictors of severe fluoropyrimidine toxicity in patients with gastrointestinal malignancies. Clin Biochem 49:1221\u20131226","journal-title":"Clin Biochem"},{"key":"3974_CR25","volume-title":"Homo brasilis: Aspectos Gen\u00e9ticos, Ling\u00fc\u00edsticos","author":"HS Klein","year":"2002","unstructured":"Klein HS (2002) Homo brasilis: Aspectos Gen\u00e9ticos, Ling\u00fc\u00edsticos. Hist\u00f3ricos e Socioantropol\u00f3gicos da Forma\u00e7\u00e3o do Povo Brasileiro, FUNPEC-RP, Ribeir\u00e3o Preto, Brasil"},{"key":"3974_CR26","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1073\/pnas.1504447112","volume":"112","author":"Kehdy FS, Gouveia MH, Machado M, Magalh\u00e3es WC, Horimoto AR, Horta BL, Moreira RG, Leal TP, Scliar MO, Soares-Souza GB, Rodrigues-Soares F, Ara\u00fajo GS, Zamudio R, Sant Anna HP, Santos HC, Duarte NE, Fiaccone RL, Figueiredo CA, Silva TM, Costa GN, Beleza S, Berg DE, Cabrera L, Debortoli G, Duarte D, Ghirotto S, Gilman RH, Gon\u00e7alves VF, Marrero AR, Muniz YC, Weissensteiner H, Yeager M, Rodrigues LC, Barreto ML, Lima-Costa MF, Pereira AC, Rodrigues MR, Tarazona-Santos E; Brazilian EPIGEN Project Consortium","year":"2015","unstructured":"Kehdy FS, Gouveia MH, Machado M, Magalh\u00e3es WC, Horimoto AR, Horta BL, Moreira RG, Leal TP, Scliar MO, Soares-Souza GB, Rodrigues-Soares F, Ara\u00fajo GS, Zamudio R, Sant Anna HP, Santos HC, Duarte NE, Fiaccone RL, Figueiredo CA, Silva TM, Costa GN, Beleza S, Berg DE, Cabrera L, Debortoli G, Duarte D, Ghirotto S, Gilman RH, Gon\u00e7alves VF, Marrero AR, Muniz YC, Weissensteiner H, Yeager M, Rodrigues LC, Barreto ML, Lima-Costa MF, Pereira AC, Rodrigues MR, Tarazona-Santos E; Brazilian EPIGEN Project Consortium (2015) Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations. Proc Natl Acad Sci USA 112:8696\u20138701","journal-title":"Proc Natl Acad Sci USA"},{"key":"3974_CR27","doi-asserted-by":"publisher","first-page":"9812","DOI":"10.1038\/srep09812","volume":"5","author":"MF Lima-Costa","year":"2015","unstructured":"Lima-Costa MF, Rodrigues LC, Barreto ML, Gouveia M, Horta BL, Mambrini J, Kehdy FS, Pereira A, Rodrigues-Soares F, Victora CG, Tarazona-Santos E, Epigen-Brazil Group (2015) Genomic ancestry and ethnoracial self-classification based on 5,871 community-dwelling Brazilians (The Epigen Initiative). Sci Rep 5:9812\u20139818","journal-title":"Sci Rep"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03974-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T11:03:03Z","timestamp":1664708583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03974-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3974"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03974-4","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"25 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}